Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRK6 | P43250 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.39 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.39 |
| ▸ | SLC29A1 | Q99808 | 3/20 | 0.37 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MANBA | O00462 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16989814 | 1.00 | GRK6 (0.40) | GRK6ALDH1A1CYP1A2NFKB1THPO | |
| SCHEMBL28640068 | 0.82 | ALDH1A1 (0.36) | GRK6ALDH1A1CYP1A2NFKB1THPO | |
| SCHEMBL28646339 | 0.82 | ALDH1A1 (0.36) | GRK6ALDH1A1CYP1A2NFKB1THPO | |
| SCHEMBL28641496 | 0.82 | ALDH1A1 (0.36) | GRK6ALDH1A1CYP1A2NFKB1THPO | |
| SCHEMBL3138140 | 0.80 | MANBA (0.38) | GRK6ALDH1A1CYP1A2NFKB1THPO | |
| SCHEMBL1292868 | 0.76 | MANBA (0.40) | GRK6ALDH1A1CYP1A2NFKB1THPO | |
| SCHEMBL7648678 | 0.76 | MANBA (0.40) | GRK6ALDH1A1CYP1A2NFKB1THPO | |
| SCHEMBL7763290 | 0.76 | PDK2 (0.39) | SLC5A1 | |
| D-Galactose SCHEMBL28081200 | 0.76 | GRK6 (0.39) | GRK6ALDH1A1CYP1A2NFKB1THPO | |
| SCHEMBL4319795 | 0.76 | LGALS3 (0.46) | ALDH1A1CYP1A2NFKB1THPOPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230301335-A1 | SPRAY-DRIED COMPOSITION COMPRISING BETA-GALACTOSIDASE HAVING TRANSGALACTOSYLATING ACTIVITY IN COMBINATION WITH MALTODEXTRIN AND/OR NACL AND APPLICATION OF THE COMPOSITION | INTERNATIONAL N&H DENMARK APS (DK) | 2023-09-28 | — | — | US | disclosed |
| EP-4165999-A1 | A METHOD FOR PREPARING A DAIRY PRODUCT HAVING A STABLE CONTENT OF GALACTO-OLIGOSACCHARIDE(S) | DuPont Nutrition Biosciences ApS (DK) | 2023-04-19 | — | — | EP | disclosed |
| US-20220159981-A1 | POLYPEPTIDES HAVING TRANSGALACTOSYLATING ACTIVITY | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2022-05-26 | — | — | US | disclosed |
| EP-3915384-A1 | RECOMBINANT HOST CELL EXPRESSING BETA-GALACTOSIDASE AND/OR TRANSGALACTOSYLATING ACTIVITY DEFICIENT IN CELLULASE | DuPont Nutrition Biosciences ApS (DK) | 2021-12-01 | — | — | EP | disclosed |
| US-20210204555-A1 | POLYPEPTIDES HAVING TRANSGALCTOSYLATING ACTIVITY | DUPONT NUTRITION BIOSCI APS (DK) | 2021-07-08 | — | — | US | disclosed |
| EP-3214942-B1 | RECOMBINANT HOST CELL EXPRESSING BETA-GALACTOSIDASE AND/OR TRANSGALACTOSYLATING ACTIVITY DEFICIENT IN MANNANASE, CELLULASE AND PECTINASE. | DUPONT NUTRITION BIOSCI APS (DK) | 2021-02-24 | — | — | EP | disclosed |
| US-20200397031-A1 | SPRAY-DRIED COMPOSITION COMPRISING BETA-GALACTOSIDASE HAVING TRANSGALACTOSYLATING ACTIVITY IN COMBINATION WITH MALTODEXTRIN AND/OR NACL AND APPLICATION OF THE COMPOSITION | INTERNATIONAL N&H DENMARK APS (DK) | 2020-12-24 | — | — | US | disclosed |
| EP-3754016-A1 | POLYPEPTIDES HAVING TRANSGALACTOSYLATING ACTIVITY | DuPont Nutrition Biosciences ApS (DK) | 2020-12-23 | — | — | EP | disclosed |
| US-10842163-B2 | Recombinant host cell expressing beta-galactosidase and/or transgalactosylating activity deficient in mannanase, cellulase and pectinase | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2020-11-24 | — | — | US | disclosed |
| US-20200296980-A1 | METHOD OF GENERATING A SACCHARIDE CONTAINING A GALACTOSE AND A FRUCTOSE MOIETY EMPLOYING ENZYME WITH TRANSGALACTOSYLATING ACTIVITY | DUPONT NUTRITION BIOSCI APS (DK) | 2020-09-24 | — | — | US | disclosed |
| US-20170318849-A1 | SPRAY-DRIED COMPOSITION COMPRISING BETA-GALACTOSIDASE HAVING TRANSGALACTOSYLATING ACTIVITY IN COMBINATION WITH MALTODEXTRIN AND/OR NACL AND APPLICATION OF THE COMPOSITION | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2017-11-09 | — | — | US | disclosed |
| EP-2859098-B1 | POLYPEPTIDES HAVING TRANSGALACTOSYLATING ACTIVITY | DUPONT NUTRITION BIOSCI APS (DK) | 2017-09-13 | — | — | EP | disclosed |
| US-20170073717-A1 | A METHOD FOR PREPARING A DAIRY PRODUCT HAVING A STABLE CONTENT OF GALACTO-OLIGOSACCHARIDE(S) | INTERNATIONAL N&H DENMARK APS (DK) | 2017-03-16 | — | — | US | disclosed |
| US-20150223481-A1 | POLYPEPTIDES HAVING TRANSGALACTOSYLATING ACTIVITY | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2015-08-13 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |